Dulaglutide · source year
7 selected, source-linked Dulaglutide records carrying a 2016 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
7 selected records.
3 represented types.
7 distinct public records.
Cited chronology
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 26179454 at 2026-07-30T21:35:57.004Z. PubMed recorded a metadata revision date of 2016-12-30 and an Entrez history date of 2015-07-17. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Regulatory
DailyMed lists Structured Product Labeling version 17 for the reviewed Dulaglutide label family with a published date of 2016-12-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory
The Federal Register published notice 2016-30399, attributed to FDA and its parent HHS department, on 2016-12-19. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY,” and PeptideScanner's exact reviewed identity mapping connects the document to Dulaglutide.
Source: Federal Register via GovInfo ↗
Regulatory
DailyMed lists Structured Product Labeling version 16 for the reviewed Dulaglutide label family with a published date of 2016-11-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 27200592 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 27200698 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT01667900 at 2026-07-30T21:38:42.858Z. Its registry update date was 2016-03-07, and PeptideScanner's reviewed identity mapping was dulaglutide.
Source: ClinicalTrials.gov ↗